By SPEAKIN’ OUT NEWS
A new experimental “keto pill” is generating national attention as researchers test whether it can mimic the effects of the popular ketogenic diet without requiring drastic changes in eating habits.
The investigational drug, known as BL-001, is designed to replicate the metabolic benefits of the ketogenic diet by targeting bacteria in the gut that influence fat metabolism. The ketogenic diet typically forces the body into a fat-burning state called ketosis by severely restricting carbohydrates.
In early clinical testing, the pill showed promising results. Overweight participants taking the highest dose lost an average of 3.4 percent of their body weight within two weeks, according to preliminary trial data.
Scientists believe the treatment works through the gut microbiome, influencing appetite control and metabolic processes linked to weight management.
“BL-001’s potential to replicate [the ketogenic diet’s] benefits in a more tolerable form of daily oral capsules opens exciting possibilities for patients,” said Christopher Reyes, Ph.D., CEO of Bloom Science, the company developing the therapy.
Researchers say the drug could eventually provide an easier alternative to strict dieting or injectable weight-loss medications such as Ozempic.
Still, experts caution that the pill is still in the early stages of development. Larger trials are underway to determine long-term safety and effectiveness.
Health specialists emphasize that while pharmaceutical breakthroughs may help address obesity, balanced nutrition and physical activity remain the foundation of healthy weight management.
If successful, the keto-mimicking pill could represent a new frontier in weight-loss treatment—one that harnesses the body’s own biology rather than extreme dietary restrictions.